Your browser doesn't support javascript.
loading
Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus.
Bruera, Sebastian; Lei, Xiudong; Zhao, Hui; Yazdany, Jinoos; Chavez-MacGregor, Mariana; Giordano, Sharon H; Suarez-Almazor, Maria E.
Afiliação
  • Bruera S; Section of Allergy, Immunology, and Rheumatology, Baylor College of Medicine, Houston, Texas, USA.
  • Lei X; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Zhao H; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Yazdany J; University of California at San Francisco, San Francisco, California, USA.
  • Chavez-MacGregor M; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Giordano SH; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Suarez-Almazor ME; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Lupus Sci Med ; 10(1)2023 02.
Article em En | MEDLINE | ID: mdl-36787921

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Lúpus Eritematoso Sistêmico Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Lúpus Eritematoso Sistêmico Idioma: En Ano de publicação: 2023 Tipo de documento: Article